Answer
Koselugo (selumetinib) is not recommended during pregnancy; there are no data in pregnant women, and animal studies have shown reproductive toxicity, including embryo-foetal death, structural defects and reduced foetal weights.
Sources for this answer
- Koselugo 5 mg granules in capsule for openingAstraZeneca UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked